Skip to main content
Jupiter Life Line Hospitals Limited logo

Jupiter Life Line Hospitals Limited — Investor Relations & Filings

Ticker · JLHL ISIN · INE682M01012 LEI · 335800O7XGF2IIMHP506 BSE.NS Human health and social work activities
Open in API
Filings indexed 249 across all filing types
Latest filing 2026-05-21 Call Transcript
Country IN India
Listing BSE.NS JLHL

About Jupiter Life Line Hospitals Limited

https://www.jupiterhospital.com/

Jupiter Life Line Hospitals Limited is a multi-specialty tertiary and quaternary care provider. The company operates full-service hospitals under the "Jupiter" brand, with major facilities located in Thane, Pune, and Indore. It offers a comprehensive suite of medical services across diverse specialties, including cardiology, oncology, neurology, nephrology, orthopaedics, and multi-organ transplants. The organization integrates advanced medical technology with specialized clinical expertise to manage complex health conditions. Its infrastructure includes dedicated centers of excellence equipped for diagnostic, surgical, and rehabilitative care. The company prioritizes clinical excellence and patient-centric service delivery, supported by a team of experienced physicians and healthcare professionals. Its operations focus on providing high-end medical interventions and specialized treatments to a broad patient base.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 95% confidence The document is the verbatim transcript of the Q4 & FY26 Results Earnings Conference Call, complete with speaker labels, moderator instructions, and Q&A. This clearly matches the definition of a Call Transcript (CT) rather than an earnings release summary or investor presentation.
2026-05-21 English
Q4 & FY 26 Earnings Conference Call - Transcript
Call Transcript Classification · 95% confidence The document is the full text transcript of Jupiter Life Line Hospitals Limited’s Q4 & FY26 earnings conference call, including speakers, moderator, management commentary, and Q&A. This matches the definition of a Call Transcript (CT).
2026-05-21 English
Updates
Regulatory Filings Classification · 85% confidence The document is a third-party secretarial compliance certificate prepared by a Practicing Company Secretary under SEBI LODR Regulation 24A, attesting to statutory and listing compliance for the year ended March 31, 2026, and submitted to stock exchanges. It contains no standalone financial statements, management discussion, or investor presentation, but rather an attestation letter. Under the certification rule, such officer certifications and compliance certificates should be classified as a general regulatory filing (RNS), not as an annual or interim report.
2026-05-18 English
Resignation
Board/Management Information Classification · 92% confidence The document is a formal intimation to stock exchanges under SEBI Listing Regulations announcing the resignation of a Non-Executive Non-Independent Director, which clearly falls under changes in the company’s board. This matches the Board/Management Information category.
2026-05-18 English
Annual Secretarial Conpliance report for the year ended March 31, 2026
Regulatory Filings Classification · 85% confidence The document is an annual Secretarial Compliance Report prepared by an external Practicing Company Secretary, certifying the company’s adherence to SEBI LODR Regulations for FY ended March 31, 2026. It is neither an annual/quarterly financial report, earnings release, nor a management/MD&A narrative, nor a shareholding or governance policy doc. It is a compliance certification filed with stock exchanges under SEBI regulations, fitting none of the specific report categories. Therefore, it falls under the catch-all "Regulatory Filings" category.
2026-05-18 English
Intimation pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations')- Resignation Letter of Dr. Bhaskar
Board/Management Information Classification · 95% confidence The document is an official intimation under SEBI Listing Regulations announcing the resignation of a Non-Executive Non-Independent Director. It details a change in the board composition and attaches the resignation letter. This aligns with the definition for Board/Management Information (MANG).
2026-05-18 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.